north of a 100 million market cap just like its peers. Currently 24 million market cap so with the upside and the news flow coming up very important period ahead and for calcium influx proven already with brain injury and secondary brain injury phase 2 going to be strong result for the company. The heart side of things I think there will be more results coming out on that in regards to indications. TRPC Receptors 3,4 and 7 like the whole heart and drug can be dosed continually avoiding neurotoxicity so conditions like Angina and arrhythmias will be indications added in.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
0.015(6.67%) |
Mkt cap ! $50.62M | |||
| Open | High | Low | Value | Volume |
| 22.5¢ | 24.0¢ | 22.5¢ | $120.9K | 510K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 20000 | 23.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 81970 | 1 |
View Market Depth
| Last trade - 15.58pm 30/06/2025 (20 minute delay) ? |
| NYR (ASX) Chart |